An expert consensus to standardize definitions , diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn ’ s disease SHORT TITLE : Novel anti-fibrotics for Crohn ’ s disease

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute; Department of Pathobiology, Lerner Research Institute; Cleveland Clinic Foundation, Cleveland, OH, USA, Department of Medicine B, University of Münster, Münster, Germany, Division of Gastroenterology, University of Calgary, Calgary, AB, Canada, Robarts Clinical Trials Inc., University of Western Ontario, London, ON, Canada, Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium, First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy, Department of Gastroenterology, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Clichy, France, Division of Gastroenterology and Hepatology, Department of